Global postpartum hemorrhage (PPH) devices market to grow at a CAGR of 5.22% during the period 2018-2022.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One driver in the market is increasing incidence of PPH. The incidence of PPH is increasing globally. PPH is the leading cause of maternal mortality. It is one of the top five causes of maternal mortality in both high and low per capita income countries. In 2016, it was estimated that globally, four out of every ten maternal deaths resulted from two causes, namely, PPH and pre-eclampsia/eclampsia. Every year, approximately, 15 million women suffer from PPH globally.
One trend in the market is increasing focus on development of alternative PPH treatment devices. Many vendors are increasingly focusing on the development of novel PPH devices. For instance, in April 2017, Clinical Innovations launched its ebb Complete Tamponade System (PPH balloon) for PPH. It allows for rapid, emergency deployment to minimize or eliminate bleeding in more than 95% of the cases.
One challenge in the market is dearth of maternity healthcare services in developing countries. A severe shortage of resources for the treatment of PPH is observed in developing countries. This is particularly acute in the countries of Africa and Asia where PPH is the leading cause of maternal mortality. More than 95% of the world's annual maternal deaths occur in developing countries. Most of the developing countries lack experienced caregivers who are trained to manage PPH successfully.